BSE · GENNEX
Gennex Laboratories Ltd
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,327
of 5,084 stocks
🏆 New peak
▲ 21W
Peak #2,327 · 30 Sep 2026
Gennex Laboratories Ltd is a microcap company in the Healthcare space and is growing revenue rapidly, has a widely-held ownership base, with promoters at just 24%, and trades at a moderate earnings multiple.
Market Cap
244.89 Cr
P/E Ratio
13.26
P/B Ratio
1.05
ROE
9.01%
ROCE
9.93%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 39.84 Cr | 60.96 Cr | 40.37 Cr | 37.24 Cr |
| Net Profit | 4.67 Cr | 4.46 Cr | 5.99 Cr | 5.51 Cr |
| EPS | 0.19 | 0.16 | 0.22 | 0.21 |
| Operating Profit | 5.82 Cr | 5.74 Cr | 8.06 Cr | 7.09 Cr |
Shareholding pattern
Promoter
23.63%
Public
76.37%
PUBLIC BREAKDOWN
DII
0.00%
Individuals
56.49%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 22 Dec 2023 | Other | E.G.M. |
| 21 Jul 2022 | Other | Right Issue of Equity Shares |
| 14 Dec 2009 | Split | Stock Split From Rs.10/- to Rs.1/- |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.